Creatine Sleep Meta-analysis: What the Evidence Says

Quick Answer

Creatine Sleep Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 randomized trial, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• As a result, creatine supports better performance in repeated high-intensity efforts and resistance training. [Gonzalez Drew E. (2026); evidence level 2]
• Multiple randomized controlled trials have confirmed that creatine leads to greater strength, higher power output, improved repeat sprint or high-intensity performance, and the ability to handle higher training volumes over time. [Gonzalez Drew E. (2026); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For creatine sleep meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Gonzalez Drew E. (2026). Creatine Supplementation Dose and Duration Are Not Associated with Increased Side Effects: A Structured Review and Study-Level Dose–Response Analysis of Randomized Controlled Trials. DOI: 10.3390/sports14040137. PMCID: PMC13120166. PMID: 42043069. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13120166/
• Kerksick Chad (2026). The emerging and evolving evidence supporting creatine as an ergogenic aid: history and applications. DOI: 10.1080/15502783.2026.2646627. PMCID: PMC13011109. PMID: 41870601. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13011109/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.